AP
IDXX icon

AHL Partners’s Idexx Laboratories IDXX Stock Holding History

AHL Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4.01M Sell
25,664
-5,782
-18% -$910K 0.06% 542
2017
Q3 		$4.89M Buy
31,446
+11,340
+56% +$1.79M 0.09% 412
2017
Q2 		$3.25M Buy
20,106
+7,784
+63% +$1.26M 0.07% 496
2017
Q1 		$1.91M Buy
12,322
+2,513
+26% +$346K 0.04% 637
2016
Q4 		$1.15M Sell
9,809
-8,096
-45% -$924K 0.04% 637
2016
Q3 		$2.02M Sell
17,905
-10,950
-38% -$1.15M 0.08% 376
2016
Q2 		$2.68M Buy
28,855
+21,842
+311% +$1.88M 0.14% 181
2016
Q1 		$550K Sell
7,013
-7,230
-51% -$521K 0.03% 559
2015
Q4 		$1.04M Sell
14,243
-1,836
-11% -$131K 0.08% 358
2015
Q3 		$1.19M Sell
16,079
-59,232
-79% -$4.24M 0.19% 187
2015
Q2 		$4.83M Buy
75,311
+36,695
+95% +$2.54M 0.19% 196
2015
Q1 		$2.98M Sell
38,616
-594
-2% -$46.2K 0.12% 419
2014
Q4 		$2.91M Buy
39,210
+7,912
+25% +$555K 0.15% 248
2014
Q3 		$1.84M Buy
+31,298
New +$1.98M 0.14% 285

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AHL Partners's IDXX Position: Q4 2017 in Review

AHL Partners reduced its Idexx Laboratories (IDXX) stake by 18% in Q4 2017, selling an estimated $910K and leaving 25,664 shares worth $4.01M. The position accounts for 0.06% of the portfolio, ranked #542.

AHL Partners first reported a position in IDXX in Q3 2014 and has held it in 14 quarters since. The position peaked at $4.89M in Q3 2017. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

  • AHL Partners held 25,664 shares of Idexx Laboratories worth $4.01M as of Q4 2017.
  • AHL Partners sold 5,782 Idexx Laboratories shares in Q4 2017, an estimated $910K.
  • Idexx Laboratories made up 0.06% of AHL Partners's portfolio in Q4 2017, its #542 holding.
  • AHL Partners first reported a position in Idexx Laboratories in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Idexx Laboratories position peaked at $4.89M in Q3 2017.
  • 613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.